Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Treace Medical Concepts's quarterly market cap
declined
from Dec. 2025 ($156.5 Mil) to Mar. 2026 ($86.8 Mil) but then
increased
from Mar. 2026 ($86.8 Mil) to Jun. 2026 ($258.6 Mil).
Treace Medical Concepts's annual market cap
declined
from Dec. 2023 ($787.3 Mil) to Dec. 2024 ($464.0 Mil) and
declined
from Dec. 2024 ($464.0 Mil) to Dec. 2025 ($156.5 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Treace Medical Concepts's Enterprise Value for Today is $338.3 Mil.
Treace Medical Concepts (NAS:TMCI) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Treace Medical Concepts Market Cap Related Terms
Treace Medical Concepts Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Treace Medical Concepts's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Treace Medical Concepts Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Treace Medical Concepts's Market Cap distribution charts can be found below:
* The bar in red indicates where Treace Medical Concepts's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Treace Medical Concepts's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Treace Medical Concepts (TMCI) has a Market Cap of $311.2 Mil as of Aug. 15, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Treace Medical Concepts and its competitors. According to the industry distribution chart, Treace Medical Concepts ranks #338 out of 861 companies in the Medical Devices & Instruments industry, placing it in the top 39.3%.
Is Treace Medical Concepts' Market Cap too high?
Treace Medical Concepts' current Market Cap is $311.2 Mil. The Medical Devices & Instruments industry median Market Cap is 118.93. Treace Medical Concepts' value of $311.2 Mil is 161.7% above this industry median. Based on the distribution chart, Treace Medical Concepts ranks #338 out of 861 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Treace Medical Concepts has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Treace Medical Concepts' Market Cap compare to TLSI and SENS?
According to the Medical Devices & Instruments industry distribution chart, Treace Medical Concepts ranks #338 out of 861 companies for Market Cap. This puts Treace Medical Concepts in the upper half of its industry. The industry median Market Cap is 118.93. Treace Medical Concepts' value of $311.2 Mil is 161.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 118.93, based on 861 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Treace Medical Concepts's current Market Cap of $311.2 Mil is 161.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Treace Medical Concepts and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 118.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Treace Medical Concepts's current Market Cap is $311.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Treace Medical Concepts stock overvalued right now?
Based on GuruFocus' analysis, Treace Medical Concepts (TMCI) is currently considered Modestly Undervalued. The stock's GF Value™ is $6.35, compared to a current price of $4.79 — trading 24.6% below its estimated fair value. The current Market Cap is $311.2 Mil and 161.7% above the Medical Devices & Instruments industry median of 118.93. Treace Medical Concepts' overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Treace Medical Concepts (TMCI), the current Market Cap is $311.2 Mil as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Treace Medical Concepts (TMCI) Overvalued in 2026?
Based on GuruFocus' analysis, Treace Medical Concepts stock appears to be undervalued.
The current stock price of $4.79 is trading 24.6% below its estimated GF Value™ of $6.35.
GuruFocus considers Treace Medical Concepts to be Modestly Undervalued.
Key valuation signals for TMCI:
Market Cap: $311.2 Mil
GF Value™: $6.35 vs. price of $4.79 (24.6% below fair value)
Industry Position: 161.7% above the Medical Devices & Instruments median (#338 of 861)
No single metric tells the full story. See the TMCI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
72GF Score
Get the complete analysis for TMCI
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TMCI has been successfully added to your 
